Page 177 - Read Online

Table 3: PERISH fl owchart Carbone PP . Toxicity and response criteria of the Eastern Cooperative
Oncology Group. Am J Clin Oncol 1982;5:649-55.
PERISH fl owchart
9. Thomas RL. Learning the alphabet of healthcare IT. Healthc Financ
Performance of the patient (ECOG)
Manage 2006;60:100-2.
Extra-hepatic disease (metastasis)
10. Stalder DR . Learning and motivational benefi ts of acronym use in
Reserve of the liver (Child-Pugh score) introductory psychology. Teach Psychol 2005;32:222-8.
Intra-hepatic distribution ( CT) 11. Liver Cancer Study Group of Japan. Primary liver cancer in Japan.
Stratifying risk factors (portal hyper-tension and bilirubin) Clinicopathologic features and results of surgical treatment. Ann Surg
Hepatectomy size (Makuuchi-ICG) 1990;211:277-87.
12. Fasani P, Sangiovanni A, De Fazio C, Borzio M, Bruno S, Ronchi G, Del
ECOG: Eastern Cooperative Oncology Group; CT: computed tomography;
Ninno E, Colombo M. High prevalence of multinodular hepatocellular
ICG: Indo-cyanine Green
carcinoma in patients with cirrhosis attributable to multiple risk factors.
Financial support and sponsorship Hepatology 1999;29:1704-7.
Nil. 13. Natsuizaka M, Omura T, Akaike T, Kuwata Y, Yamazaki K, Sato T,
Karino Y, Toyota J, Suga T, Asaka M. Clinical features of hepatocellular
carcinoma with extrahepatic metastases. J Gastroenterol Hepatol
Confl ict of interest 2005;20:1781-7.
There is no conflict of interest. 14. Sasaki Y, Imaoka S, Shibata T, Wada H, Nagano H, Ishikawa O,
Furukawa H, Fukuda I, Kyoama H, Doi O. Successful surgical
management of pulmonary and adrenal metastases from hepatocellular
REFERENCES carcinoma. Eur J Surg Oncol 1991;17:84-90.
15. Manizate F, Hiotis SP, Labow D, Roayaie S, Schwartz M. Liver
1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. functional reserve estimation: State of the art and relevance for local
CA Cancer J Clin 2005;55:74-108. treatments: the Western perspective. J Hepatobiliary Pancreat Sci
2. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 2010;17:385-8.
2003;362:1907-17. 16. Franco D, Capussotti L, Smadja C, Bouzari H, Meakins J, Kemeny F,
3. Chang MH, You SL, Chen CJ, Liu CJ, Lee CM, Lin SM, Chu HC, Wu TC, Grange D, Dellepiane M. Resection of hepatocellular carcinomas.
Yang SS, Kuo HS, Chen DS; Taiwan Hepatoma Study Group. Decreased Results in 72 European patients with cirrhosis. Gastroenterology
incidence of hepatocellular carcinoma in hepatitis B vaccinees: a 20-year 1990;98:733-8.
follow-up study. J Natl Cancer Inst 2009;101:1348-55. 17. Nagasue N, Yukaya H, Kohno H, Chang YC, Nakamura T. Morbidity
4. Llovet JM, Di Bisceglie AM, Bruix J, Kramer BS, Lencioni R, Zhu AX, and mortality after major hepatic resection in cirrhotic patients with
Sherman M, Schwartz M, Lotze M, Talwalkar J, Gores GJ; Panel of hepatocellular carcinoma. HPB Surg 1988;1:45-56.
Experts in HCC-Design Clinical Trials. Design and endpoints of clinical 18. Llovet JM, Fuster J, Bruix J. Intention-to-treat analysis of surgical
trials in hepatocellular carcinoma. J Natl Cancer Inst 2008;100:698-711. treatment for early hepatocellular carcinoma: resection versus
5. El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma transplantation. Hepatology 1999;30:1434-40.
in the United States. N Engl J Med 1999;340:745-50. 19. Nagasue N, Yukaya H, Ogawa Y, Kohno H, Nakamura T. Human liver
6. Sirivatanauksorn Y, Tovikkai C. Comparison of staging systems of regeneration after major hepatic resection. A study of normal liver and
hepatocellular carcinoma. HPB Surg 2011;2011:818217. livers with chronic hepatitis and cirrhosis. Ann Surg 1987;206:30-9.
7. Llovet JM, Brú C, Bruix J. Prognosis of hepatocellular carcinoma: the 20. Makuuchi M, Kosuge T, Takayama T, Yamazaki S, Kakazu T,
BCLC staging classifi cation. Semin Liver Dis 1999;19:329-38. Miyagawa S, Kawasaki S. Surgery for small liver cancers. Semin Surg
8. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Oncol 1993;9:298-304.

170 Hepatoma Research | Volume 1 | Issue 3 | October 15, 2015